Ayako Shoji

667 total citations
34 papers, 464 citations indexed

About

Ayako Shoji is a scholar working on Molecular Biology, Genetics and Epidemiology. According to data from OpenAlex, Ayako Shoji has authored 34 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Genetics and 5 papers in Epidemiology. Recurrent topics in Ayako Shoji's work include Chronic Lymphocytic Leukemia Research (5 papers), Rheumatoid Arthritis Research and Therapies (4 papers) and Lymphoma Diagnosis and Treatment (3 papers). Ayako Shoji is often cited by papers focused on Chronic Lymphocytic Leukemia Research (5 papers), Rheumatoid Arthritis Research and Therapies (4 papers) and Lymphoma Diagnosis and Treatment (3 papers). Ayako Shoji collaborates with scholars based in Japan, United States and United Kingdom. Ayako Shoji's co-authors include Setsuo Hirohashi, Tesshi Yamada, Kazufumi Honda, Miki Shitashige, Umio Yamaguchi, Akira Kawai, Robert Nakayama, Masakado Kawata, Shoji Kawamura and Ole Seehausen and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Ayako Shoji

30 papers receiving 451 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ayako Shoji Japan 9 169 115 103 92 85 34 464
Yuko Kubo Japan 10 111 0.7× 101 0.9× 92 0.9× 27 0.3× 81 1.0× 39 367
Hongying Huang United States 15 342 2.0× 66 0.6× 119 1.2× 47 0.5× 208 2.4× 34 689
R. De Vita Italy 11 92 0.5× 59 0.5× 86 0.8× 126 1.4× 77 0.9× 26 368
Cosimo Martinelli France 11 535 3.2× 63 0.5× 78 0.8× 568 6.2× 329 3.9× 11 1.2k
Kate Hall United Kingdom 13 417 2.5× 127 1.1× 62 0.6× 56 0.6× 26 0.3× 28 840
A. Behmel Austria 12 449 2.7× 177 1.5× 31 0.3× 71 0.8× 78 0.9× 18 960
Nisha Padmanabhan United Kingdom 14 457 2.7× 148 1.3× 79 0.8× 188 2.0× 46 0.5× 19 832
Jason Baum United States 11 348 2.1× 258 2.2× 110 1.1× 52 0.6× 35 0.4× 30 656
Fleur Hammet Australia 14 391 2.3× 166 1.4× 59 0.6× 202 2.2× 44 0.5× 32 750

Countries citing papers authored by Ayako Shoji

Since Specialization
Citations

This map shows the geographic impact of Ayako Shoji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ayako Shoji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ayako Shoji more than expected).

Fields of papers citing papers by Ayako Shoji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ayako Shoji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ayako Shoji. The network helps show where Ayako Shoji may publish in the future.

Co-authorship network of co-authors of Ayako Shoji

This figure shows the co-authorship network connecting the top 25 collaborators of Ayako Shoji. A scholar is included among the top collaborators of Ayako Shoji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ayako Shoji. Ayako Shoji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Inoue, Yuichi, et al.. (2025). Clinical challenges in narcolepsy: From delayed diagnosis to daytime function impairments during treatment. Sleep Medicine. 131. 106496–106496. 1 indexed citations
3.
Matsuoka, Katsuyoshi, Ataru Igarashi, Noriko Sato, et al.. (2025). Clinical characteristics of patients with difficult-to-treat ulcerative colitis: a nested case-control study using a Japanese claims database. Intestinal Research. 24(1). 103–116.
6.
Momohara, Shigeki, Kei Ikeda, Masahiro Tada, et al.. (2023). Patient–Physician Communication and Perception of Treatment Goals in Rheumatoid Arthritis: An Online Survey of Patients and Physicians. Rheumatology and Therapy. 10(4). 917–931. 3 indexed citations
8.
Takedani, Hideyuki, et al.. (2023). Linguistic validation of Barriers to Being Active Quiz (BBAQ-21) in Japanese patients with hemophilia. Japanese Journal of Thrombosis and Hemostasis. 34(3). 381–393.
9.
Tanaka, Eiichi, Eisuke Inoue, Ayako Shoji, et al.. (2022). Cost-consequence of abatacept as first-line therapy in Japanese rheumatoid arthritis patients using IORRA real-world data. PLoS ONE. 17(11). e0277566–e0277566. 3 indexed citations
10.
Shoji, Ayako, et al.. (2022). 30-year trends of hip and vertebral fracture incidence in Japan: a systematic review and meta-analysis. Journal of Bone and Mineral Metabolism. 40(2). 327–336. 5 indexed citations
11.
Kadowaki, Takashi, et al.. (2022). Characteristics of subjects with type 2 diabetes enrolled in randomized controlled trials and non‐randomized controlled trials in Japan: A systematic review. Journal of Diabetes Investigation. 14(2). 236–246. 1 indexed citations
12.
Shoji, Ayako, et al.. (2022). Reduction in medical costs for cardiovascular diseases through innovative health awareness projects in a rural area in Japan. PLoS ONE. 17(11). e0277600–e0277600. 2 indexed citations
13.
Shoji, Ayako, et al.. (2020). Cost-effectiveness analysis of treatment regimens with obinutuzumab plus chemotherapy in Japan for untreated follicular lymphoma patients. Journal of Medical Economics. 23(10). 1130–1141. 4 indexed citations
14.
Shoji, Ayako, et al.. (2019). PCV74 COST REDUCTION AFTER THE INDUCTION OF THE RESIDENT ENLIGHTMENT BASED ON MEDICAL CHECKUP IN A JAPANESE RURAL AREA. Value in Health. 22. S132–S132. 1 indexed citations
15.
16.
Kawamura, Shoji, Satoshi Kasagi, Daisuke Kasai, et al.. (2016). Spectral sensitivity of guppy visual pigments reconstituted in vitro to resolve association of opsins with cone cell types. Vision Research. 127. 67–73. 31 indexed citations
17.
Kobayashi, Eisuke, Mari Masuda, Robert Nakayama, et al.. (2010). Reduced Argininosuccinate Synthetase Is a Predictive Biomarker for the Development of Pulmonary Metastasis in Patients with Osteosarcoma. Molecular Cancer Therapeutics. 9(3). 535–544. 97 indexed citations
18.
Matsubara, Junichi, Masaya Ono, Kazufumi Honda, et al.. (2010). Survival Prediction for Pancreatic Cancer Patients Receiving Gemcitabine Treatment. Molecular & Cellular Proteomics. 9(4). 695–704. 31 indexed citations
19.
Yamaguchi, Umio, Kazufumi Honda, Reiko Satow, et al.. (2009). Functional genome screen for therapeutic targets of osteosarcoma. Cancer Science. 100(12). 2268–2274. 28 indexed citations
20.
Yamaguchi, Umio, Robert Nakayama, Kazufumi Honda, et al.. (2008). Distinct Gene Expression–Defined Classes of Gastrointestinal Stromal Tumor. Journal of Clinical Oncology. 26(25). 4100–4108. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026